Treatment for Skin Lupus
Hydroxychloroquine is the cornerstone treatment for cutaneous lupus erythematosus (CLE), recommended at a dose of 200-400 mg daily for chronic discoid lupus erythematosus. 1
First-Line Treatments
Photoprotection
- Sun protection is essential as most CLE patients are photosensitive
- Recommend:
- Broad-spectrum sunscreens
- Protective clothing
- Behavioral modifications to avoid UV exposure
Topical Therapies
Topical Corticosteroids
- First-line topical treatment for localized lesions
- Use medium to high potency for body lesions
- Lower potency for face, intertriginous areas
- Caution: Limited long-term use due to side effects (skin atrophy, telangiectasia)
Topical Calcineurin Inhibitors (tacrolimus, pimecrolimus)
- Effective alternative, especially for facial lesions
- Steroid-sparing agents for sensitive areas
- No risk of skin atrophy
Systemic Therapies
Antimalarials
Hydroxychloroquine (HCQ)
- Dosage: 200-400 mg daily (single dose or divided doses) 1
- First-line systemic therapy for all forms of CLE
- Takes 6-8 weeks for full effect
- Regular ophthalmologic monitoring required
Chloroquine
- Alternative when HCQ is not effective
- Higher risk of retinal toxicity than HCQ
Quinacrine
- Can be added to HCQ or chloroquine for refractory cases
- No risk of retinal toxicity
Systemic Corticosteroids
- Reserved for acute flares or severe disease
- Short-term use recommended (lowest effective dose)
- Aim to taper to ≤7.5 mg/day of prednisolone or equivalent 2
- Not recommended for long-term management due to significant side effects
Second-Line Therapies for Refractory Cases
Immunomodulators
Methotrexate
- Effective for recalcitrant CLE
- Weekly dosing regimen
Mycophenolate Mofetil
- Alternative for refractory cases
- Particularly useful when there is concurrent lupus nephritis
Azathioprine
- Used as maintenance therapy after initial disease control 2
Other Options
Retinoids (acitretin)
- Effective for hyperkeratotic variants
- Teratogenic - contraception required
Thalidomide/Lenalidomide
- Reserved for severe, refractory cases
- Significant risk of peripheral neuropathy
- Strict contraception required (teratogenic)
Dapsone
- Particularly effective for bullous lupus erythematosus
- Requires G6PD screening before initiation
Biologic Therapies
- Belimumab has moderate evidence for efficacy in CLE 3
- Consider in cases refractory to conventional therapies
Important Considerations
Contraindications
- UVB phototherapy is contraindicated in patients with lupus erythematosus 4
Lifestyle Modifications
- Smoking cessation is crucial - smoking reduces efficacy of antimalarials
- Vitamin D optimization recommended
Treatment Algorithm
- Start with photoprotection + topical therapies for limited disease
- Add hydroxychloroquine for widespread disease or inadequate response to topicals
- Consider short course of systemic steroids for acute flares
- For refractory disease: add second antimalarial or switch to immunomodulator
- Consider biologics or thalidomide for severe recalcitrant disease
Monitoring
- Regular assessment of disease activity
- Ophthalmologic monitoring for patients on antimalarials
- Laboratory monitoring based on specific medications used
The treatment approach should follow a stepwise progression, with careful consideration of disease severity, extent, and individual response to therapy.